Added: 08.04.2015 22:30 | 32 views | 0 comments

Added: 08.04.2015 20:00 | 15 views | 0 comments




[Update] The existence of Deus Ex: Mankind Divided is now official, and developer Eidos Montreal has released an announcement trailer to mark the occasion.

Additional details about the game have also been revealed. Mankind Divided takes place two years after the events of Human Revolution and features Adam Jensen as the protagonist once again. He operates as a counter-terrorism agent and attempts to stop attacks that threaten to fuel the segregation of augmented individuals from the rest of society.

Added: 08.04.2015 19:26 | 11 views | 0 comments



A day after Deus Ex: Mankind Divided's first details and screenshots leaked, Eidos Montreal has officially announced the game. The debut trailer for Mankind Divided gives us some valuable insight into the story of the futuristic adventure.

Added: 08.04.2015 19:17 | 9 views | 0 comments


GearNuke writes: "Deus Ex: Mankind Divided was just announced with an amazing trailer for the Xbox One, PS4 and PC. Like its prequel, Human Revolution, the trailer featured an epic track that developers Eidos Montreal were nice enough to upload on their Soundcloud incase someone wanted to give the original track a listen without the dialogue."

Added: 07.04.2015 22:17 | 9 views | 0 comments


The original Deus Ex is one of the most critically acclaimed shooter/RPG hybrids of all-time. In 2011, Eidos-Montreal resurrected the dormant franchise with Human Revolution, giving the series an updated look while remaining true to the player choice-driven gameplay. Eidos-Montreal knew its game wasnt perfect, and has worked to improve the series' combat systems and boss encounters for the latest entry in the series Mankind Divided.

Added: 07.04.2015 21:19 | 11 views | 0 comments



Eidos Montreal is making a sequel to Deus Ex: Human Revolution. The first details and screenshots from Deus Ex: Mankind Divided were leaked by a Russian gaming site before Square Enix could formally announce them.

Added: 30.03.2015 17:03 | 11 views | 0 comments


Join us for two hours of Rainbow Six Siege with the Ubisoft Montreal development team, starting at 11am PT/2pm ET/7pm GMT.

Added: 03.03.2015 17:00 | 25 views | 0 comments

Around 9 million people in the United States are affected by Amblyopia, making it the number one cause of monocular blindness, according to representatives from Amblyotech. For the past two hundred years, one of the leading treatments for children affected with Amblyopia was to have them wear an eyepatch over their strong eye to stimulate better vision in the weaker one.

However, this form of "patching" therapy is not ideal, according to Ubisoft and Amblyotech.

“While current treatments options, such as eye patching, provide limited relief and have poor patient compliance due to discomfort and social stigmas, the Amblyotech-patented electronic therapy has been tested clinically to significantly increase the visual acuity of both children and adults who suffer from this condition without the use of an eye patch," Amblyotech CEO Joseph Koziak said. "With our agreement with Ubisoft, we are further able to provide physicians with a complete and accurate picture of treatment compliance to help them monitor patient progress throughout therapy."

For its part, Ubisoft senior producer Mathie Ferland called Dig Rush--in development at Ubisoft Montreal--a "breakthrough novel medical treatment" for Amblyopia.

Dig Rush, a basic side-scrolling game, utilizes both eyes to train the brain in an effort to improve visual acuity. This is done by utilizing different contrast levels of red and blue seen through stereoscopic glasses that the player wears. The game itself, played on a tablet, can automatically adjust to a person's specific eye condition. The game also naturally adapts later on as visual acuity improves.

Another issue with the patching treatment for Amblyopia, developers said, is that patients are prone to relapse after the therapy has ended. But all signs are positive so far for Dig Rush as an alternative. About 90 percent of patients have seen improvements during early testing, measuring better visual acuity just 4-6 weeks later after they started played the game.

Developers noted that the patching method is only successful about 25 percent of the time.

Amblyotech is now seeking FDA approval for Dig Rush and hopes to offer the game later this year. But you won't be able to head to iTunes and simply download the game. It will be available only through a physician's prescription. Amblyotech representatives said they see Dig Rush as a drug just like any other. It's the "next generation of a syringe," they said.

Tablets will come pre-loaded with Dig Rush and patients are asked to play about an hour per day for 4-6 weeks to see lasting results. Data from the game is measured in real time and sent to a doctor to ensure patients are following their prescription. After all, a drug only works if you take it in the proper dosage.

So how did Dig Rush come to be? Ferland recalled visiting a "hacking" event in Montreal and, by chance, he heard about about McGill researcher Dr. Robert Hess' attempts to treat Amblyopia with video games using Amblyotech's app. He approached Hess and Amblyotech about a potential partnership, and the companies have been working together since.

Amblyotech's early prototype for its game was quite rudimentary and not very fun to play, the company admitted. But after all, they aren't game designers. That's why the company jumped at the opportunity to work with Ubisoft on the project.

Of course, Ubisoft's work on Dig Rush doesn't mean they'll stop making Assassin's Creed or Far Cry games anytime soon. What do you make of Ubisoft's new moves? Let us know in the comments below!

Added: 03.03.2015 17:00 | 8 views | 0 comments

Around 9 million people in the United States are affected by Amblyopia, making it the number one cause of monocular blindness, according to representatives from Amblyotech. For the past two hundred years, one of the leading treatments for children affected with Amblyopia was to have them wear an eyepatch over their strong eye to stimulate better vision in the weaker one.

However, this form of "patching" therapy is not ideal, according to Ubisoft and Amblyotech.

“While current treatments options, such as eye patching, provide limited relief and have poor patient compliance due to discomfort and social stigmas, the Amblyotech-patented electronic therapy has been tested clinically to significantly increase the visual acuity of both children and adults who suffer from this condition without the use of an eye patch," Amblyotech CEO Joseph Koziak said. "With our agreement with Ubisoft, we are further able to provide physicians with a complete and accurate picture of treatment compliance to help them monitor patient progress throughout therapy."

For its part, Ubisoft senior producer Mathie Ferland called Dig Rush--in development at Ubisoft Montreal--a "breakthrough novel medical treatment" for Amblyopia.

Dig Rush, a basic side-scrolling game, utilizes both eyes to train the brain in an effort to improve visual acuity. This is done by utilizing different contrast levels of red and blue seen through stereoscopic glasses that the player wears. The game itself, played on a tablet, can automatically adjust to a person's specific eye condition. The game also naturally adapts later on as visual acuity improves.

Another issue with the patching treatment for Amblyopia, developers said, is that patients are prone to relapse after the therapy has ended. But all signs are positive so far for Dig Rush as an alternative. About 90 percent of patients have seen improvements during early testing, measuring better visual acuity just 4-6 weeks later after they started played the game.

Developers noted that the patching method is only successful about 25 percent of the time.

Amblyotech is now seeking FDA approval for Dig Rush and hopes to offer the game later this year. But you won't be able to head to iTunes and simply download the game. It will be available only through a physician's prescription. Amblyotech representatives said they see Dig Rush as a drug just like any other. It's the "next generation of a syringe," they said.

Tablets will come pre-loaded with Dig Rush and patients are asked to play about an hour per day for 4-6 weeks to see lasting results. Data from the game is measured in real time and sent to a doctor to ensure patients are following their prescription. After all, a drug only works if you take it in the proper dosage.

So how did Dig Rush come to be? Ferland recalled visiting a "hacking" event in Montreal and, by chance, he heard about about McGill researcher Dr. Robert Hess' attempts to treat Amblyopia with video games using Amblyotech's app. He approached Hess and Amblyotech about a potential partnership, and the companies have been working together since.

Amblyotech's early prototype for its game was quite rudimentary and not very fun to play, the company admitted. But after all, they aren't game designers. That's why the company jumped at the opportunity to work with Ubisoft on the project.

Of course, Ubisoft's work on Dig Rush doesn't mean they'll stop making Assassin's Creed or Far Cry games anytime soon. What do you make of Ubisoft's new moves? Let us know in the comments below!